OptimizeRx (OPRX) Free Cash Flow (2010 - 2026)

OptimizeRx (OPRX) has 17 years of Free Cash Flow data on file, last reported at -$488000.0 in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow fell 112.82% year-over-year to -$488000.0; the trailing twelve-month figure through Mar 2026 stood at $14.4 million (up 121.02% YoY), and the FY2025 full-year result was $18.7 million, up 290.56% from the prior year.
• Free Cash Flow declined to -$488000.0 in Q1 2026, from $7.1 million in the prior quarter.
• In the past five years, Free Cash Flow ranged from a high of $7.1 million in Q4 2025 to a low of -$7.0 million in Q4 2023.
• A 5-year average of $1.5 million and a median of $1.6 million in 2024 frame the typical range for Free Cash Flow.
• Across the five-year window, Free Cash Flow sank 949.35% in 2023 and jumped 2118.38% in 2025, its largest moves.
• Tracing OPRX's Free Cash Flow over 5 years: stood at $2.7 million in 2022, then sank by 357.34% to -$7.0 million in 2023, then jumped by 104.61% to $321000.0 in 2024, then jumped by 2118.38% to $7.1 million in 2025, then plunged by 106.85% to -$488000.0 in 2026.
• Business Quant data shows OPRX's Free Cash Flow at -$488000.0 in Q1 2026, $7.1 million in Q4 2025, and $3.1 million in Q3 2025.